期刊文献+

2009-2011年四川省疑似预防接种异常反应监测评价 被引量:12

Surveillance of Adverse Events Following Immunization in Sichuan,2009-2011
原文传递
导出
摘要 目的评价四川省疑似预防接种异常反应(Adverse Events Following Immunization,AEFI)监测工作开展情况,分析AEFI的发生特征和预防接种服务质量。方法收集2009-2011年全国AEFI监测系统上报的四川省AEFI监测数据,用描述性流行病学方法对相关数据进行分析。结果截止2011-12-31,四川省96.20%的县报告了AEFI,共报告AEFI病例2325例,其中9月、6月和4月报告病例较多,男性多于女性,≤1岁儿童占30.75%;接种后0~1d发生占79.05%;一般反应和异常反应占87.06%,偶合症次之,其他原因极少;国家免疫规划(NIP)疫苗AEFI报告发生率为0.35/100万剂~64.25/100万剂,远低于预期发生数。结论四川省AEFI监测的及时性、完整性和敏感性较低,监测质量需进一步提高;AEFI常发生在小年龄儿童和接种早期,为AEFI监测的重点。 Objective To evaluate the implementation of the surveillance on adverse events following immunization (AEFI) in Siehuan province, and to analyze the characteristics of AEFI as well as the service quality of vacci-nation. Methods Monitoring data of AEFI reported by Sichuan province during 2009-2011 from the national AEFI monitoring system was collected and analyzed with the method of descriptive epidemiology. Results By December 31st. 2011,96.20% counties in Sichuan reported AEFI. A total of 2 325 cases of AEFI were repor- ted, mainly distributed in September, June and April. Among the cases, more males were reported than fe-males; children under 1 year old accounted for 30. 75% of the total; AEFI occurred within 1 day after inocula-tion accounted for 79.05%. Among the causes, the general reaction and abnormal response accounted for 87.06% of the total, followed by coupling, and other causes were few. The reported incidence rate of AEFI o-riginated from the national immunization program (NIP) vaccine was 0. 35-64.25 per one million agents, far less than the expected number. Conclusion The timeliness, integrity and sensitivity of AEFI monitoring in Si-chuan province are comparatively low; the quality needs to be further improved. AEFI often occurs among young children and in the early stage after vaccinating, which should be the focus of monitoring.
出处 《预防医学情报杂志》 CAS 2013年第5期367-370,共4页 Journal of Preventive Medicine Information
关键词 疑似预防接种异常反应 监测 adverse events following immunization(AEFI) surveillance
  • 相关文献

参考文献5

二级参考文献27

  • 1郭飚.全球预防接种副反应监测系统的建立与发展[J].中国计划免疫,2005,11(3):229-233. 被引量:63
  • 2郭飚,曹雷,曹玲生,徐立君,梁晓峰,张振国,罗耀星,孙印旗,彭国文,赵占杰.河北、广东省预防接种副反应监测试点培训效果评估[J].中国计划免疫,2005,11(4):302-305. 被引量:34
  • 3庄菱,郭飚,刘大卫,曹玲生,曹雷.全国预防接种异常反应监测省级师资培训效果评估[J].中国计划免疫,2006,12(3):218-220. 被引量:9
  • 4刘大卫.如何开展预防接种异常反应监测工作[J].中国计划免疫,2006,12(4):322-327. 被引量:65
  • 5WHO/Immunization Vaccines and Biologicals(IVB). Joint Medical Products Assessment Tools of National Regulatory System Vaccines Assessment[S]. Geneva, Switzerland, 2004.
  • 6WHO&WPRO. Immunization safety surveillance:guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization[S]. Manila, Philiodines. 1999.
  • 7国家统计局.2009年中国统计年鉴[M].北京:中国统计出版社,2009.
  • 8Weigong Zhou, Vitali Pool, John K, et al. Surveillance for Safety After Immunization:Vaccine Adverse Event Reporting System (VAERS)- United States, 1991-2001 [J]. MMWR, 2003, 52 (No.SS-1): 1-24.
  • 9卫生部.《2009年秋冬季甲型H1N1流感疫苗预防接种指导意见》[S].2009.
  • 10WHO&WPRO.Immunization safety surveillance: guidelines for managers of immunization pragrammes on reporting and investigating adverse events following immunization[S]. Manila, Philippines, 1999.

共引文献306

同被引文献64

  • 1陈映莲,郑可珊,柯銮芝,詹丹萌,李荔.38例吸附百白破疫苗接种副反应分析和预防对策[J].现代护理,2006,12(13):1236-1237. 被引量:8
  • 2刘大卫.如何开展预防接种异常反应监测工作[J].中国计划免疫,2006,12(4):322-327. 被引量:65
  • 3卫生部.全国疑似预防接种异常反应监测方案[S].2010-06-03.
  • 4卫生部、国家药品食品监督管理局.全国疑似预防接种异常反应监测方案[S].2010.6.
  • 5卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].北京:卫生部,2010.
  • 6史久华,徐冰.免疫接种安全性监测[M].北京:人民卫生出版社,2008:8-29.
  • 7WHO&WPRO.Immunization safety surveillance:guidelines for managers of immunization pmgrammes on reporting and investigating adverse events following irmnunization[S].Manila, Philippines, 1999 : 1 1.
  • 8中华人民共和国卫生部.全国疑似预防接种异常反应监测方案[S].2010.
  • 9四川省卫生厅,四川省财政厅.四川省预防接种异常反应补偿办法[s].2011.
  • 10WHO&WPRO.Immunization safety surveillance:guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization[S].Manila,Philiodines,1999-12-03.

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部